Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • cameroninbaghdad cameroninbaghdad Feb 11, 2013 1:27 PM Flag

    Wait for short interest numbers after close today

    And all the weak hands who sold because of this lame article will realize the mistake they made. Last short interest numbers showed a drop of 1 million shares from 4.4 to 3.4 million. Today's numbers I am certain will be below 3 million and closer to 2.5 million. Mark this post.

    The run will start later this month, probably later this week. I expect that on Feb 28th during the conference call Chris will state the FDA meeting already happened and went well, with the company waiting on official meeting minutes. This will run to 40 on speculation of AA and will cross the 52 week high of 45 easily when they receive it. My target price after AA announcement is 55-60 and I see it staying at that level until summertime when they sumbit NDA. After a successful Adcom this should break 100 and eventually run to 130 on approval in Q1 2014. The FDA fully understands the PR nightmare they will have on their hands if they don't even allow this drug to go up in front of an advisory panel. I have little doubts of AA and put the chances of denial at 5%.

    Good luck to all of you true longs who realize how the game is played and don't b1tch and moan with every price fluctuation.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
12.22-0.01(-0.08%)Feb 5 4:00 PMEST